A citation-based method for searching scientific literature

Soo Youn Bae, Sangmin Kim, Jun Ho Lee, Hyun-Chul Lee, Se Kyung Lee, Won Ho Kil, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam. BMC Cancer 2015
Times Cited: 78







List of co-cited articles
437 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Emad A Rakha, Maysa E El-Sayed, Andrew R Green, E Claire Paish, Desmond G Powe, Julia Gee, Robert I Nicholson, Andrew H S Lee, John F R Robertson, Ian O Ellis. J Clin Oncol 2007
205
25

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
Xiaojiang Cui, Rachel Schiff, Grazia Arpino, C Kent Osborne, Adrian V Lee. J Clin Oncol 2005
332
24

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.
Aleix Prat, Maggie Chon U Cheang, Miguel Martín, Joel S Parker, Eva Carrasco, Rosalía Caballero, Scott Tyldesley, Karen Gelmon, Philip S Bernard, Torsten O Nielsen,[...]. J Clin Oncol 2013
342
24

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
23


Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Lisa K Dunnwald, Mary Anne Rossing, Christopher I Li. Breast Cancer Res 2007
458
19

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.
C A Purdie, P Quinlan, L B Jordan, A Ashfield, S Ogston, J A Dewar, A M Thompson. Br J Cancer 2014
101
19

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Grazia Arpino, Heidi Weiss, Adrian V Lee, Rachel Schiff, Sabino De Placido, C Kent Osborne, Richard M Elledge. J Natl Cancer Inst 2005
367
16

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, Philippe Moerman, Nathalie Pochet, Wouter Hendrickx, Hans Wildiers, Robert Paridaens, Ann Smeets, Marie-Rose Christiaens,[...]. J Clin Oncol 2008
74
14

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
12

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
12

Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype.
Marco M Hefti, Rong Hu, Nicholas W Knoblauch, Laura C Collins, Benjamin Haibe-Kains, Rulla M Tamimi, Andrew H Beck. Breast Cancer Res 2013
87
12

Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
Syed Salahuddin Ahmed, Aye Aye Thike, Kathryn Zhang, Jeffrey Chun Tatt Lim, Puay Hoon Tan. J Clin Pathol 2017
23
43

Time to stop progesterone receptor testing in breast cancer management.
Ivo A Olivotto, Pauline T Truong, Caroline H Speers, Vanessa Bernstein, Sharon J Allan, Seamus J Kelly, Mary L Lesperance. J Clin Oncol 2004
62
16

Lack of either estrogen or progesterone receptor expression is associated with poor survival outcome among luminal A breast cancer subtype.
Seho Park, Byeong-Woo Park, Tae Hyun Kim, Chang Wan Jeon, Han-Sung Kang, Jung-Eun Choi, Ki-Tae Hwang, In Cheol Kim. Ann Surg Oncol 2013
25
36

Progesterone receptor modulates ERα action in breast cancer.
Hisham Mohammed, I Alasdair Russell, Rory Stark, Oscar M Rueda, Theresa E Hickey, Gerard A Tarulli, Aurelien A Serandour, Stephen N Birrell, Alejandra Bruna, Amel Saadi,[...]. Nature 2015
349
11


Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Giuseppe Viale, Meredith M Regan, Eugenio Maiorano, Mauro G Mastropasqua, Patrizia Dell'Orto, Birgitte Bruun Rasmussen, Johnny Raffoul, Patrick Neven, Zsolt Orosz, Stephen Braye,[...]. J Clin Oncol 2007
311
11

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
10


Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
A S Coates, E P Winer, A Goldhirsch, R D Gelber, M Gnant, M Piccart-Gebhart, B Thürlimann, H-J Senn. Ann Oncol 2015
10

Intrinsic breast cancer subtypes defined by estrogen receptor signalling-prognostic relevance of progesterone receptor loss.
Lisa Braun, Friederike Mietzsch, Petra Seibold, Andreas Schneeweiss, Peter Schirmacher, Jenny Chang-Claude, Hans Peter Sinn, Sebastian Aulmann. Mod Pathol 2013
35
22

Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.
Mehrdad Nadji, Carmen Gomez-Fernandez, Parvin Ganjei-Azar, Azorides R Morales. Am J Clin Pathol 2005
297
10

Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer.
Tiansheng Shen, Margaret Brandwein-Gensler, Omar Hameed, Gene P Siegal, Shi Wei. Hum Pathol 2015
26
30

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson,[...]. N Engl J Med 2018
866
10

Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Yunhai Li, Dejuan Yang, Xuedong Yin, Xiang Zhang, Jiefeng Huang, Yusheng Wu, Mengxue Wang, Zhiying Yi, Hongyuan Li, Hongzhong Li,[...]. JAMA Netw Open 2020
30
26


Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment.
Ke-da Yu, Gen-hong Di, Jiong Wu, Jin-song Lu, Kun-wei Shen, Guang-yu Liu, Zhen-zhou Shen, Zhio-ming Shao. J Cancer Res Clin Oncol 2008
35
20

Risk factors for breast cancer according to estrogen and progesterone receptor status.
Graham A Colditz, Bernard A Rosner, Wendy Y Chen, Michelle D Holmes, Susan E Hankinson. J Natl Cancer Inst 2004
366
7

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.
G Cancello, P Maisonneuve, N Rotmensz, G Viale, M G Mastropasqua, G Pruneri, E Montagna, M Iorfida, M Mazza, A Balduzzi,[...]. Ann Oncol 2013
73
8


Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
7

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
7


Estrogen receptor negative and progesterone receptor positive breast carcinomas-how frequent are they?
Gábor Cserni, Monika Francz, Endre Kálmán, Gyöngyi Kelemen, Detre Csaba Komjáthy, Ilona Kovács, Janina Kulka, László Sarkadi, Nóra Udvarhelyi, László Vass,[...]. Pathol Oncol Res 2011
25
24

Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Mitsuya Itoh, Takayuki Iwamoto, Junji Matsuoka, Tomohiro Nogami, Takayuki Motoki, Tadahiko Shien, Naruto Taira, Naoki Niikura, Naoki Hayashi, Shoichiro Ohtani,[...]. Breast Cancer Res Treat 2014
59
10

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer.
Melissa Chan, Martin C Chang, Rosa González, Belinda Lategan, Elvira del Barco, Francisco Vera-Badillo, Paula Quesada, Robyn Goldstein, Ignacio Cruz, Alberto Ocana,[...]. PLoS One 2015
28
21

Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity?
Jawad Kiani, Afrasyab Khan, Hina Khawar, Fawad Shuaib, Shahid Pervez. Pathol Oncol Res 2006
22
27


Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?
Niamh M Foley, J M Coll, A J Lowery, S O Hynes, M J Kerin, M Sheehan, C Brodie, K J Sweeney. Pathol Oncol Res 2018
15
40



Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
6

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, E Rutgers, S Zackrisson, F Cardoso. Ann Oncol 2015
887
6

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
6


Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Mitch Dowsett, Torsten O Nielsen, Roger A'Hern, John Bartlett, R Charles Coombes, Jack Cuzick, Matthew Ellis, N Lynn Henry, Judith C Hugh, Tracy Lively,[...]. J Natl Cancer Inst 2011
6

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
Shuzhen Liu, Stephen K Chia, Erika Mehl, Samuel Leung, Ashish Rajput, Maggie C U Cheang, Torsten O Nielsen. Breast Cancer Res Treat 2010
84
6

Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study.
Mitch Dowsett, Jack Cuzick, Chris Wale, Tony Howell, Joan Houghton, Michael Baum. J Clin Oncol 2005
188
6

It is not time to stop progesterone receptor testing in breast cancer.
R Colomer, M Beltran, J Dorcas, H Cortes-Funes, J Hornedo, V Valentin, C Vargas, C Mendiola, E Ciruelos. J Clin Oncol 2005
27
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.